Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 30pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5932417: Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
30 pages

 
Inventor: Birnbaumer, Lutz; Los Angeles, CA
Zhu, Xi; Los Angeles, CA

Assignee: The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
 News, Profiles, Stocks and More about this company

Published / Filed: 1999-08-03 / 1996-10-15

Application Number: US1996000729955

IPC Code: Advanced: C07K 14/47; C07K 14/705; A61K 38/00;
Core: C07K 14/435; more...
IPC-7: C07H 21/04; C12N 15/00; C12N 15/85; C12Q 1/68;

ECLA Code: C07K14/47; C07K14/705;

U.S. Class: Current: 435/006; 435/069.1; 435/325; 435/375; 536/023.1; 536/024.5;
Original: 435/006; 435/069.1; 435/172.3; 435/325; 435/375; 536/023.1; 536/024.5;

Field of Search: 435/004,6,69.1,325,172.3,375 536/23.1,24.5 514/044

Government Interest:     This invention was made with government support under Grant No. HL-45198 from the National Institutes of Health. The Government has certain rights in this invention.

Priority Number:
1996-10-15  US1996000729955

Abstract: A method for controlling capacitative calcium ion entry into a mammalian cell. The method is based on the discovery that mammalian transient receptor potential (trp) protein are essential for calcium ion entry. Two human trp proteins are disclosed. Htrp1 and Htrp3. The method involves treating cells with a trp-control agent to either raise or lower the amount of biologically active trp protein associated with the cell to thereby control capacitative calcium ion entry into the cell. Screening methods are also disclosed based upon using mammalian trp protein as a screening target.

Attorney, Agent or Firm: Oppenheimer Wolff & Donnelly LLP ;

Primary / Asst. Examiners: LeGuyader, John L.; Wang, Andrew

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

Designated Country: AU CA EP JP 

Family: Show 3 known family members

First Claim:
Show all 3 claims
We claim:     1. A method of screening a compound for controlling capacitative calcium ion entry into mammalian cells, said method comprising the steps of:
  • providing a cell culture which expresses a transient receptor potential protein which is selected from the group consisting of Htrm1 and Htrp3, said cell expressing said transient receptor potential protein to provide a naturally occurring level of biologically active transient receptor potential protein associated with said cell;
  • exposing said cell culture to said compound; and
  • determining if the exposure of said cell culture to said compound increases or decreases the expression of said transient receptor potential protein to thereby provide an indication of the compound's potential use in controlling capacitative calcium ion entry into mammalian cells.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 1 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (1)   |   Backward references (1)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 41pp US5670330  1997-09 Sonenberg et al.  McGill University Anti-tumor agent assay using PKR
       
Foreign References: None

Other Abstract Info: CHEMABS 128(19)226220V DERABS C1998-230269

Other References:
  • Vaca et al., Activation of recombinant trp by thapsigargin in sf9 insect cells, American Journal of Physiology, vol. 267 (5, pt.1), pp. c1501-1505, 1994. (5 pages) [ISI abstract]
  • Verma et al., Gene therapy-promises, problems and prospects, Nature, vol. 389, pp. 239-242, Sep. 18, 1997. (4 pages) Cited by 1060 patents [ISI abstract]
  • Zhu et al., Molecular cloning of a widely expressed human homologue for the Drosophila trp gene, FEBS Letters, vol. 373, pp. 193-198, Oct. 1995. (6 pages) Cited by 4 patents [ISI abstract]
  • Mulligan, The basic science of gene therapy, Science, vol. 260, pp. 926-932, May 14, 1993. (7 pages) Cited by 319 patents [ISI abstract]
  • Wes et al., TRPC1, a human homolog of a Drosophila store-operated channel, Proc. Natl. Acad. Sci., vol. 92, pp. 9652-9656, Oct. 1995. (5 pages) Cited by 4 patents [ISI abstract]


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help